Just Published: "Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2014 Update"
Vermillion, Inc. (Vermillion) is a healthcare service provider. The company develops and commercializes multi-marker, diagnostic tests, which addresses unmet needs in gynecologic oncology and women's health. It manufactures OVA1 product. Vermillion's research and development center develops and validates biomarkers and algorithms. The company collaborates with other academic institutions in oncology, cardiology and women's health. It partners with Johns Hopkins University School of Medicine, University of Kentucky, and Stanford University. The company offers its services to patients in various states in...
View full press release